SPI-62 as a Treatment for Adrenocorticotropic Hormone-dependent Cushing's Syndrome
Public ClinicalTrials.gov record NCT05307328. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Study identification
- NCT ID
- NCT05307328
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sparrow Pharmaceuticals
- Industry
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- SPI-62 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2022
- Primary completion
- Jul 31, 2025
- Completion
- Jul 31, 2025
- Last update posted
- Oct 7, 2025
2022 – 2025
United States locations
- U.S. sites
- 8
- U.S. states
- 8
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| St. Joseph's Hospital and Medical Center - Barrow Neurological Institute (BNI) - Pituitary Center | Phoenix | Arizona | 85013 | — |
| Southwest General Healthcare Center | Fort Myers | Florida | 33907 | — |
| Mayo Clinic Cancer Center (MCCC) - Rochester | Rochester | Minnesota | 55905 | — |
| Washington University School of Medicine - Center for Advanced Medicine (CAM) | St Louis | Missouri | 63110 | — |
| Comprehensive and Interventional Pain Management Llp | Henderson | Nevada | 89052 | — |
| Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | — |
| Oregon Health & Science University (OHSU) - Northwest Pituitary Center | Portland | Oregon | 97239 | — |
| University of Pittsburgh Medical Center | Pittsburgh | Pennsylvania | 15213 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05307328, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 7, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05307328 live on ClinicalTrials.gov.